NCT06347809View on ClinicalTrials.gov

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 23, 2019

Primary Completion Date

February 1, 2029

Study Completion Date

February 1, 2029

Conditions
Prostate AdenocarcinomaProstate Carcinoma
Interventions
OTHER

Non-Interventional Study

Non-Interventional Study

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06347809 - DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine | Biotech Hunter | Biotech Hunter